drugset / Trial / NCT00058214

Perifosine in Treating Patients With Recurrent Prostate Cancer

NCT00058214

Phase 2 Terminated 25 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of perifosine in treating patients who have recurrent prostate cancer. Drugs used in chemotherapy such as perifosine use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
2003-03
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Perifosine Small molecule Oral